Form 8-K - Current report:
SEC Accession No. 0001104659-20-049780
Filing Date
2020-04-22
Accepted
2020-04-22 17:23:53
Documents
5
Period of Report
2020-04-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2016643-1_8k.htm 8-K 37888
2 EXHIBIT 4.1 tm2016643d1_4-1.htm EX-4.1 104576
3 EXHIBIT 10.1 tm2016643d1_10-1.htm EX-10.1 57482
4 EXHIBIT 99.1 tm2016643d1_99-1.htm EX-99.1 16200
5 GRAPHIC tm2016643d1_ex99-1img01.jpg GRAPHIC 3363
  Complete submission text file 0001104659-20-049780.txt   222199
Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 (781) 810-0120
Entasis Therapeutics Holdings Inc. (Filer) CIK: 0001724344 (see all company filings)

EIN.: 824592913 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38670 | Film No.: 20808609
SIC: 2834 Pharmaceutical Preparations